Modifying risks of secondary leukemias: is drug scheduling important?

MLN4924 induces Noxa upregulation in acute myelogenous leukemia and synergizes with Bcl-2 inhibitors.

Cell death and differentiation·2015

A phase Ib study of vosaroxin, an anticancer quinolone derivative, in patients with relapsed or refractory acute leukemia.

Leukemia·2011

A pharmacodynamic study of sorafenib in patients with relapsed and refractory acute leukemias.

Leukemia·2010

Induction of acute lymphocytic leukemia differentiation by maintenance therapy.

Leukemia·2007

Fluorescent in situ hybridization (FISH) in bone marrow and peripheral blood of leukemia patients: implications for occupational surveillance.

Mutation research·2007

JAK2 V617F is a rare finding in de novo acute myeloid leukemia, but STAT3 activation is common and remains unexplained.

Leukemia·2006

Prospective multicenter validation of a Urine-Based multiplex assay for risk stratification of patients presenting with gross hematuria.

Journal of the National Cancer Institute·2026

Cervical human papillomavirus status among women with chronic inflammatory rheumatic diseases: matched cohort study.

Journal of the National Cancer Institute·2026

Refining risk stratification of patients with early breast cancer eligible for adjuvant abemaciclib or ribociclib.

Journal of the National Cancer Institute·2026

Somatic alterations in TP53, PIK3CA, and CCND1 reveal exposure-driven patterns in oral and oropharyngeal tumors.

Journal of the National Cancer Institute·2026

Inhibitors of IAP/XIAP enhance activity of sacituzumab govitecan.

Journal of the National Cancer Institute·2026

Examining the role of extrachromosomal DNA in lung cancer.

Journal of the National Cancer Institute·2026

Treatment sequence with gilteritinib and allogeneic haematopoietic stem cell transplantation in relapsed/refractory FMS-like tyrosine kinase 3 (FLT3)-mutated acute myeloid leukaemia patients: A multicentre real-world study.

British journal of haematology·2026

Salvage treatment patterns in multiple myeloma patients progressing after lenalidomide maintenance: A real-life study from European Myeloma Network (EMN) Italy.

British journal of haematology·2026

Cytodiagnostic features of angiofibroma of soft tissue: A review of 16 cases to identify characteristic findings and their diagnostic significance.

Cancer cytopathology·2026

Transforming lymphoma outcomes through international real-world data collaborations: the Global Lymphoma Registry Alliance roadmap.

Haematologica·2026

Prognostic relevance of RUNX1 mutations at acute myeloid leukemia diagnosis and as measurable residual disease marker before and after allogeneic stem cell transplantation.

Haematologica·2026

Related Experiment Videos

Modifying risks of secondary leukemias: is drug scheduling important?

Related Concept Videos

MLN4924 induces Noxa upregulation in acute myelogenous leukemia and synergizes with Bcl-2 inhibitors.

A phase Ib study of vosaroxin, an anticancer quinolone derivative, in patients with relapsed or refractory acute leukemia.

A pharmacodynamic study of sorafenib in patients with relapsed and refractory acute leukemias.

Induction of acute lymphocytic leukemia differentiation by maintenance therapy.

Fluorescent in situ hybridization (FISH) in bone marrow and peripheral blood of leukemia patients: implications for occupational surveillance.

JAK2 V617F is a rare finding in de novo acute myeloid leukemia, but STAT3 activation is common and remains unexplained.

Prospective multicenter validation of a Urine-Based multiplex assay for risk stratification of patients presenting with gross hematuria.

Cervical human papillomavirus status among women with chronic inflammatory rheumatic diseases: matched cohort study.

Refining risk stratification of patients with early breast cancer eligible for adjuvant abemaciclib or ribociclib.

Somatic alterations in TP53, PIK3CA, and CCND1 reveal exposure-driven patterns in oral and oropharyngeal tumors.

Inhibitors of IAP/XIAP enhance activity of sacituzumab govitecan.

Examining the role of extrachromosomal DNA in lung cancer.

Treatment sequence with gilteritinib and allogeneic haematopoietic stem cell transplantation in relapsed/refractory FMS-like tyrosine kinase 3 (FLT3)-mutated acute myeloid leukaemia patients: A multicentre real-world study.

Salvage treatment patterns in multiple myeloma patients progressing after lenalidomide maintenance: A real-life study from European Myeloma Network (EMN) Italy.

Cytodiagnostic features of angiofibroma of soft tissue: A review of 16 cases to identify characteristic findings and their diagnostic significance.

Transforming lymphoma outcomes through international real-world data collaborations: the Global Lymphoma Registry Alliance roadmap.

Prognostic relevance of RUNX1 mutations at acute myeloid leukemia diagnosis and as measurable residual disease marker before and after allogeneic stem cell transplantation.

Related Experiment Videos

Modifying risks of secondary leukemias: is drug scheduling important?

Related Concept Videos

Related Articles